Top Story

Zoledronic acid discontinuation safe for some women after 3 years

October 27, 2014

Women who demonstrate a total hip T-score above –2.5 with no recent incident fracture and no more than one risk factor after 3 years on zoledronic acid are at low risk for subsequent fracture after stopping therapy, according to research in The Journal of Clinical Endocrinology & Metabolism.

Through a 3-year randomized multicenter extension of the HORIZON trial, Felicia Cosman, MD, of the Helen Hayes Hospital, West Haverstraw, N.Y., and colleagues from other institutions determined that treatment discontinuation for up to 3 years in this group is reasonable.

Unexpected vertebral fractures

October 24, 2014
Steve (not his real name) presented to the clinic with a recent history of vertebral fractures. He is 68 inches tall, weighs in at 170 lb., with a BMI of 26, and a pain…
figure In the Journals

New report highlights osteoporosis prevalence in men, calls for action

October 14, 2014
Representing one-third of hip fractures worldwide, men have mortality rates as high as 37% in the first year following fracture, doubling the risk of death in…

Survey: Fewer than half of postmenopausal women take bone health supplements

October 12, 2014
A recent survey conducted by AIDP Inc. found that although women are well aware of the risks of brittle bones and fractures, fewer than half take bone health…
CME
figure

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
CME
figure

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »

Filter By:

In the Journals

Zoledronic acid discontinuation safe for some women after 3 years

October 27, 2014
Women who demonstrate a total hip T-score above –2.5 with no recent incident fracture and no more than one risk factor after 3 years on…

Unexpected vertebral fractures

October 24, 2014
Steve (not his real name) presented to the clinic with a recent history of vertebral fractures. He is 68 inches tall, weighs in at 170 lb., with a…
figure In the Journals

New report highlights osteoporosis prevalence in men, calls for action

October 14, 2014
Representing one-third of hip fractures worldwide, men have mortality rates as high as 37% in the first year following fracture, doubling…

Survey: Fewer than half of postmenopausal women take bone health supplements

October 12, 2014
A recent survey conducted by AIDP Inc. found that although women are well aware of the risks of brittle bones and fractures, fewer than half take…
In the Journals

Vigorous physical activity helped predict hip, spine bone mineral content in children

October 7, 2014
Vigorous-intensity physical activity helped predict bone mineral content at two skeletal sites in children and adolescents, according to research…
In the Journals

Calcium-sensing receptor antagonist did not improve BMD in postmenopausal women

October 6, 2014
Transient pulses of parathyroid hormone occurred in postmenopausal women with osteoporosis treated with the orally bioavailable calcium-sensing…
In the Journals

Low blood levels of vitamin D linked to poorer QOL, self-rated health in older patients

October 6, 2014
Among older individuals, lower blood levels of 25-hydroxyvitamin D are associated with poorer self-reported quality of life and health, according to…
FDA News

Bioequivalent estradiol patch approved for new indication dose

September 27, 2014
The FDA has approved a 33% smaller dose of the estradiol transdermal system for the prevention of postmenopausal osteoporosis, according to the…
Meeting News Coverage

Denosumab shows promise for osteoporotic women at high risk for fracture

September 23, 2014
Women with osteoporosis who are at high risk for fracture adhered to denosumab therapy better than other osteoporosis treatments over time, according…
figure Meeting News Coverage

Vitamin D therapy improved deficiency rates of middle-aged women

September 22, 2014
Supplements containing vitamin D helped women of varying race, ethnicity, socioeconomic status and education levels increase their long-term levels…
More Headlines »